These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24394806)

  • 1. Oral beclomethasone dipropionate in chronic refractory pouchitis.
    Gionchetti P; Calabrese C; Calafiore A; Praticò C; Poggioli G; Laureti S; Capozzi N; Campieri M; Rizzello F
    J Crohns Colitis; 2014 Jul; 8(7):649-53. PubMed ID: 24394806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
    Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.
    Abdelrazeq AS; Kelly SM; Lund JN; Leveson SH
    Colorectal Dis; 2005 Mar; 7(2):182-6. PubMed ID: 15720360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose probiotics for the treatment of active pouchitis.
    Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
    Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
    Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
    Gut; 2004 Jan; 53(1):108-14. PubMed ID: 14684584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis.
    Shen B; Pardi DS; Bennett AE; Queener E; Kammer P; Hammel JP; LaPlaca C; Harris MS
    Am J Gastroenterol; 2009 Jun; 104(6):1468-74. PubMed ID: 19436282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.
    Shen B; Fazio VW; Remzi FH; Bennett AE; Lopez R; Brzezinski A; Oikonomou I; Sherman KK; Lashner BA
    Dis Colon Rectum; 2007 Apr; 50(4):498-508. PubMed ID: 17279300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
    Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
    Aliment Pharmacol Ther; 2002 May; 16(5):909-17. PubMed ID: 11966499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral budesonide in the treatment of chronic refractory pouchitis].
    Cabriada Nuño JL; Hernández Martín A; Bernal Martínez A; Zabalza Estévez I
    Gastroenterol Hepatol; 2008 Oct; 31(8):485-9. PubMed ID: 18928746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial.
    Kjær MD; Qvist N; Nordgaard-Lassen I; Christensen LA; Kjeldsen J
    Scand J Gastroenterol; 2019 Feb; 54(2):188-193. PubMed ID: 30739519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vedolizumab for the Treatment of Chronic Pouchitis.
    Travis S; Silverberg MS; Danese S; Gionchetti P; Löwenberg M; Jairath V; Feagan BG; Bressler B; Ferrante M; Hart A; Lindner D; Escher A; Jones S; Shen B;
    N Engl J Med; 2023 Mar; 388(13):1191-1200. PubMed ID: 36988594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.
    Gionchetti P; Rizzello F; Venturi A; Ugolini F; Rossi M; Brigidi P; Johansson R; Ferrieri A; Poggioli G; Campieri M
    Aliment Pharmacol Ther; 1999 Jun; 13(6):713-8. PubMed ID: 10383499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis.
    Miner P; Wedel M; Bane B; Bradley J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):281-6. PubMed ID: 14984374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics.
    Kohyama M; Takesue Y; Ohge H; Murakami Y; Shimamoto F; Sueda T
    Surg Today; 2009; 39(11):962-8. PubMed ID: 19882318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.
    Nunes T; Barreiro-de Acosta M; Nos P; Marin-Jiménez I; Bermejo F; Ceballos D; Iglesias E; Gomez-Senent S; Torres Y; Ponferrada A; Arevalo JA; Hernandez V; Calvet X; Ginard D; Monfort D; Chaparro M; Manceñido N; Domínguez-Antonaya M; Villalón C; Perez-Calle JL; Muñoz C; Nuñez H; Carpio D; Aramendiz R; Bujanda L; Estrada-Oncins S; Hermida C; Barrio J; Casis MB; Dueñas-Sadornil MC; Fernández L; Calvo-Cenizo MM; Botella B; de Francisco R; Ayala E; Sans M;
    J Crohns Colitis; 2010 Dec; 4(6):629-36. PubMed ID: 21122572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
    Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis.
    Bär F; Kühbacher T; Dietrich NA; Krause T; Stallmach A; Teich N; Schreiber S; Walldorf J; Schmelz R; Büning C; Fellermann K; Büning J; Helwig U;
    Aliment Pharmacol Ther; 2018 Mar; 47(5):581-587. PubMed ID: 29266360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis.
    Viazis N; Giakoumis M; Koukouratos T; Anastasiou J; Katopodi K; Kechagias G; Anastasopoulos E; Saprikis E; Chanias M; Tribonias G; Karamanolis DG
    J Crohns Colitis; 2013 Nov; 7(10):e457-60. PubMed ID: 23523672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tacrolimus therapy for antibiotic-refractory pouchitis.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Hida N; Nakamura S; Takesue Y; Tomita N
    Dis Colon Rectum; 2013 Oct; 56(10):1166-73. PubMed ID: 24022534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.